StockCIK 1761612

BICYCLE THERAPEUTICS PLC (BCYC): Insider Trades and Fund Holdings

In the past 12 months, BICYCLE THERAPEUTICS PLC insiders reported 0 open-market purchases worth $0 and 12 sales worth $63K; 3 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$63KSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 7, 2026.

Recent BCYC insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 7	Oct 5	Jennifer Scott PerryCOO	COO	▼ SELL10b5-1	30	3.57	$107	+0.0%	Form 4 ↗
Oct 6	Oct 2	Kevin LeeCEO	CEO	▼ SELL	6,167	3.47	$21K	−1.0%	Form 4 ↗
Oct 6	Oct 2	Robert Charles SwantonDirector	Director	▼ SELL	3,431	3.47	$12K	−18%	Form 4 ↗
Oct 6	Oct 2	Michael SkynnerCHIEF SCIENTIFIC OFFICER	CHIEF SCIENTIFIC OFFICER	▼ SELL	1,942	3.47	$7K	−1.2%	Form 4 ↗
Oct 6	Oct 5	Kevin LeeCEO	CEO	▼ SELL	1,638	3.57	$6K	−0.3%	Form 4 ↗
Oct 6	Oct 2	Michael Charles Ferguson HannayCHIEF PROD & SUPPLY CHAIN OFF	CHIEF PROD & SUPPLY CHAIN OFF	▼ SELL	1,572	3.47	$5K	−1.7%	Form 4 ↗
Oct 6	Oct 2	Jennifer Scott PerryCOO	COO	▼ SELL10b5-1	1,094	3.47	$4K	−1.2%	Form 4 ↗
Oct 6	Oct 2	Travis Alvin ThompsonCFO	CFO	▼ SELL	893	3.47	$3K	−1.4%	Form 4 ↗
Oct 6	Oct 5	Michael SkynnerCHIEF SCIENTIFIC OFFICER	CHIEF SCIENTIFIC OFFICER	▼ SELL	503	3.57	$2K	−0.3%	Form 4 ↗
Oct 6	Oct 5	Jennifer Scott PerryCOO	COO	▼ SELL10b5-1	406	3.74	$2K	−0.5%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

All 12 BCYC insider trades →

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Jennifer Scott Perry	COO	$0	3	$5K	Oct 7, 2026
Kevin Lee	CEO	$0	2	$27K	Oct 6, 2026
Robert Charles Swanton	Director	$0	1	$12K	Oct 6, 2026
Michael Skynner	CHIEF SCIENTIFIC OFFICER	$0	2	$9K	Oct 6, 2026
Michael Charles Ferguson Hannay	CHIEF PROD & SUPPLY CHAIN OFF	$0	2	$6K	Oct 6, 2026
Travis Alvin Thompson	CFO	$0	2	$3K	Oct 6, 2026

Tracked funds that report BCYC

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	1,533,400	$6.50M	0.01%	▲ +56.6%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →